Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects

In-house & bespoke training:

Management Forum’s biopharma and biotech training courses will provide delegates with an overview of how biotech products are developed and manufactured as well as giving delegates an update on the scientific and regulatory environment, including biologic patent expiration and advances through biotech innovation.



In-house & bespoke training

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

Rated by attendees to the public programme

Typically presented by Hans van Bruggen (bio) , Marloes van der Geer (bio)

Typical duration: 2 days
Pricing from £800 per attendee
Delivery: collaborative classroom

View details

Biotechnology for the Non-Biotechnologist

In-house & bespoke training

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Rated by attendees to the public programme

Typically presented by Adrian Haines (bio)
and 6 more leading experts

Typical duration: 3 days
Pricing from £1,200 per attendee
Delivery: collaborative classroom

View details

The level of detail and complexity was just right and I have learnt a lot and would certainly recommend this course to others. I thoroughly enjoyed the course.

Melanie Pires, Pharmaceutical Assessor, Medicines and Healthcare Products Regulatory Agency (MHRA)

Every speaker brought in their own experience and passion that should offer something for attendants from a variety of backgrounds and levels of detail, and certainly did for mine...Excellent content for somebody lacking a bio or chemistry background providing a clear and useful understanding of the building blocks that make up the biotech industry.

Patrick Helm, Sr. Associate Contract Management, Genmab B.V.

Excellent course with expert speakers. It is highly recommended to people who already have a background on life sciences.

Mary Malamatari, Assessor, Medicines and Healthcare Products Regulatory Agency (MHRA)

The content was excellent and all presenters were clearly SMEs, who managed to explain much of the complex content in an understandable way.

Sunil Singh, Director, Regulink Ltd

Excellent. Really enjoyed and learned a lot.

Anthony Barker, Director - Regulatory CMC, Home Address

I gained much more understanding than what I had intended to. The trainer also involved everybody in the course and did not make it boring. The topics of non-clinical, clinical, strategy as well as market entry/IP etc were covered briefly too. So that was an added advantage.

Anjali Apte, Manager, Regulatory Affairs, PharmaLex UK Services Ltd

The webinar was very good overall with very comprehensive material and understandable throughout. The speakers were very knowledgeable and were open to questions and comments and answered them very professionally.

Tomas Orn Sigurbjornsson, Sourcing Lead, Alvotech

I really enjoyed the course and I have already recommended it.

Paolo Gasbarrone, Principal scientist, Merck group

The presentations were well prepared in general and I learned a lot.

Katja Pecjak, Director of Regulatory Affairs & QPPV, Billev farmacija vzhod d.o.o

Globally good presentation, speaker tried to make people participate which is difficult by webinar.

Frédéric LALLEMAND, Consultant, Lallemand Conseil